Report cover image

Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Oth

Publisher Coherent Market Insights
Published May 13, 2022
Length 326 Pages
SKU # CMI17213318

Description

Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Lyophilization or freeze drying is the process in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient, protein, collagen, peptide, oligonucleotide, enzymes, and mAbs (Monoclonal Antibody)
Market Dynamics
Key market players are focusing on increasing product launches and approvals, which is expected drive the growth of the market over forecast period. For instance, in May 2019, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., received the U.S. Food and Drug Administration (FDA) approval for a new dosage form (50 mg) and two new indications for pembrolizumab available as a lyophilized powder (Keytruda): Non–small-cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC). Additionally, in December 2021, Novartis AG, a global healthcare company, announced that the European Commission (EC) approved Xolair (omalizumab) as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe chronic rhinosinusitis with nasal polyps (CRSwNP), where therapy only with INC does not provide adequate disease control.
Key features of the study:
This report provides an in-depth analysis of the global lyophilized product market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lyophilized product market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Merck & Co., Inc., Fresenius Kabi AG, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Glaxosmithkline Plc, Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co. Ltd., BTG PLC, Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, Biogen Inc., Dr. Reddy's Laboratories Ltd., Zydus Cadila, AbbVie Inc., Cipla Inc., Johnson & Johnson Services, Inc., Affy Pharma Private Limited, Jubilant Pharmova Limited, and Biocon
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global lyophilized product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lyophilized product market
Detailed Segmentation:
Global Lyophilized Product Market, By Drug Class:
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAIDs
Others
Global Lyophilized Product Market, By Indication:
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
Global Lyophilized Product Market, Packaging Type:
Vial
Syringes
Cartridge
Global Lyophilized Product Market, By Region:
North America
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
U.S.
Canada
Latin America
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
GCC
Israel
Rest of Middle East
Africa
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Sanofi*
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Fresenius Kabi AG
Ciron Drugs & Pharmaceuticals Pvt. Ltd
Glaxosmithkline Plc
Mylan NV.
Pfizer, Inc.
Amneal Pharmaceuticals LLC
Otsuka Holdings Co. Ltd.
BTG PLC
Bristol-Myers Squibb Company
Novartis AG
Takeda Pharmaceutical Company Limited
Biogen Inc.
Dr. Reddy's Laboratories Ltd.
Zydus Cadila
AbbVie Inc.
Cipla Inc.
Johnson & Johnson Services, Inc.
Affy Pharma Private Limited
Jubilant Pharmova Limited
Biocon
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

326 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Indication
Market Snapshot, By Packaging Type
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Lyophilization Overview
Drivers and Restraint
Market Opportunity
Market Trends
Impact Analysis
Key Developments
Regulatory Scenario
Reimbursement Scenario
Unmet Needs
Challenges in Lyophilization
PEST Analysis
Pipeline Analysis
Customer- supplier Database (Country Wise)
4. Global Lyophilized Product Market – Impact of Coronavirus (COVID-19) Pandemic
Impact On Supply And Demand
Government Initiatives
COVID-19 Epidemiology
5. Global Lyophilized Product Market, By Drug Class, 2017 - 2028, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Anti-infective
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Antineoplastic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Diuretics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Proton Pump Inhibitor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Anesthetic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Anticoagulant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
NSAIDs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
6. Global Lyophilized Product Market , By Indication, 2017 - 2028, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Infectious Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Autoimmune Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Gastrointestinal Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Lyophilized Product Market, By Packaging Type, 2017 - 2028, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Vials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cartridge
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Lyophilized Product Market , By Region, 2017 - 2028, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2022 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2028
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Bn)
Brazil
Mexico
Argentina
Peru
Paraguay
Uruguay
Ecuador
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Bn)
Germany
U.K.
France
Italy
Spain
Russia
Portugal
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Bn)
China
India
Japan
Australia
ASEAN
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2017 - 2028, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2017 - 2028, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Sanofi*
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Fresenius Kabi AG
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Ciron Drugs & Pharmaceuticals Pvt. Ltd.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Glaxosmithkline Plc
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Mylan N.V.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer, Inc.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
ABneal Pharmaceuticals LLC
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Otsuka Holdings Co. Ltd.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
BTG PLC
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Takeda Pharmaceutical Company Limited
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Biogen Inc.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Dr. Reddy's Laboratories Ltd.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Zydus Cadila
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
AbbVie Inc.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Cipla Inc.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson Services, Inc.
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Affy Pharma Private Limited
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Jubilant Pharmova Limited
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Biocon
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 35 market data tables and 33 figures on "Lyophilized Product Market” - Global forecast to 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us